Sagent debuts injection drug
SCHAUMBURG - Sagent Pharmaceuticals Inc. Wednesday announced the launch of chlorothiazide codium for injection, a diuretic/antihypertensive agent in single-dose vial. It is used for therapy for edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy.
Chlorothiazide sodium for injection has also been found useful in edema due to various forms of renal dysfunction, such as nephrotic syndrome, acute glomerulonephritis, and chronic renal failure, according to the company.
Article Comments
Guidelines: Keep it civil and on topic; no profanity, vulgarity, slurs or personal attacks. People who harass others or joke about tragedies will be blocked.
If a comment violates these standards or our terms of service, click the "flag" link in the lower-right corner of the comment box. To find our more, read our FAQ.